Pierangeli S S, Gharavi A E, Harris E N
Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310-1495, USA.
Clin Obstet Gynecol. 2001 Mar;44(1):48-57; quiz 58-9. doi: 10.1097/00003081-200103000-00007.
The first aCL test was developed in 1983 and subsequently standardized. Although new and more specific tests have become available, the aCL ELISA and the LA tests are still the first choice to be used in diagnosis of APS. Newer tests such as the anti beta 2 GP1 ELISA and the APhL ELISA Kit (Louisville APL Diagnostics) use somewhat different antigens and likely provide a more specific (and possibly more reliable) diagnosis of APS while retaining good-to-excellent sensitivity. Other tests, such as ELISA for prothrombin antibodies and annexin V antibodies, are still undergoing development and will require standardization and extensive evaluation. We thank Dr Isabel Abreu and Dr Mittermeyer B. Santiago for performing some of the studies reported in this review.
首次抗心磷脂抗体(aCL)检测于1983年开发并随后标准化。尽管已有更新且更具特异性的检测方法,但aCL酶联免疫吸附测定(ELISA)和狼疮抗凝物(LA)检测仍是诊断抗磷脂综合征(APS)的首选方法。较新的检测方法,如抗β2糖蛋白1 ELISA和APhL ELISA试剂盒(路易斯维尔抗磷脂诊断公司)使用的抗原略有不同,在保持良好至极佳敏感性的同时,可能会为APS提供更具特异性(且可能更可靠)的诊断。其他检测方法,如凝血酶原抗体ELISA和膜联蛋白V抗体ELISA,仍在研发中,需要进行标准化和广泛评估。我们感谢伊莎贝尔·阿布雷乌博士和米特迈耶·B·圣地亚哥博士进行了本综述中报道的部分研究。